Investorideas.com

Call 800 665 0411 to learn about our services for your stock

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS




Share on StockTwits

US VC funding off to a slow start as deal volume and value decline by 61.2% and 37% YoY in January 2024

 

February 20, 2024 (Investorideas.com Newswire) The US venture capital (VC) funding activity made a slow start in 2024, with the first month of the year seeing a year-on-year (YoY) decline in deals volume and value by 61.2% and 37% compared to January 2023, respectively, according to GlobalData, a leading data and analytics company.

An analysis of GlobalData's Deals Database reveals that a total of 281 VC funding deals worth $5.1 billion were announced in the US during January 2024 compared to the announcement of 725 VC funding deals with a disclosed funding value of $8 billion during the same period in the previous year.

Aurojyoti Bose, Lead Analyst at GlobalData, comments: "Several start-ups began the new year with layoff announcements. For instance, Aurora Solar, DispatchHealth, Brex, and Noom were among the many other start-ups, which were in the news in January due to their layoff announcements. This suggests that the funding winter is far from getting over, and resultantly, we are seeing start-ups across several key markets, including the US, struggling to raise funds as investors seem to have become extra cautious."


Despite the decline, the US still continues to be the largest market for VC funding activity globally, both in terms of value and volume. The US accounted for 24.6% of the total number of VC funding deals announced globally during January 2024, while its share of the corresponding disclosed deal value stood at 36%.

Some of the notable VC funding deals announced in the US during January 2024 included $140 million worth of funding raised by Zum Services Inc, $105 million secured by COUR Pharma, $102 million funding received by Synnovation Therapeutics, and $100 million secured by ExtraHop Networks and Second Dinner each.

Moreover, the US also saw the birth of three unicorns, Quantinuum, Zum Services, and Eleven Labs Inc., in January 2024. Interestingly, two of these are active in the AI space. While ElevenLabs is an AI voice cloning start-up, Zum Services is deploying AI-powered innovation for student transportation.

Note: Historic data may change in case some deals get added to previous months because of a delay in the disclosure of information in the public domain

Notes to Editors

  • Quotes are provided by Aurojyoti Bose, Lead Analyst at GlobalData
  • The information is based on GlobalData's Financial Deals Database
  • This press release was written using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData's team of industry experts.

About GlobalData

4,000 of the world's largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make more timely and better business decisions thanks to GlobalData's unique data, expert analysis and innovative solutions, all in one platform. GlobalData's mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.

More Info:


Investorideas.com Newswire

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp


That's all it takes to get an article published on Investor Ideas - Learn More